Cornhulio, following link on current proceedings.
December 7, 2016 - UC Davis to Conduct Phase 2 Trial of the Combination of TG4010 with Opdivo® (nivolumab) for 2nd Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC) / The trial will be supported by Transgene and Bristol-Myers Squibb http://www.transgene.fr/wp-content/...7-Collaboration_UC_Davis_Transgene-BMS_EN.pdf
- Forums
- ASX - By Stock
- VHL - Transgene TG4011 & TG4010
Cornhulio, following link on current proceedings. December 7,...
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.82M |
Open | High | Low | Value | Volume |
4.2¢ | 4.2¢ | 4.2¢ | $17.55K | 418.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 80471 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 225514 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 80471 | 0.042 |
3 | 1034391 | 0.041 |
9 | 797493 | 0.040 |
5 | 389000 | 0.039 |
2 | 225000 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 225514 | 2 |
0.045 | 831675 | 6 |
0.047 | 525000 | 2 |
0.048 | 58027 | 1 |
0.050 | 310539 | 3 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |